Epioxa Cross-linking Kit
Product Images NDC 25357-024

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Epioxa Cross-linking (NDC 25357-024). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaukos Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Epioxa 01)

Chemical structure of riboflavin 5-phosphate, the active ingredient in EPIOXA CROSS-LINKING ophthalmic kit by Glaukos Corporation.*

FDA Label Image

Principal Display Panel (Kit Carton)

Packaging label for EPIOXA CROSS-LINKING kit by Glaukos Corporation, a human prescription ophthalmic drug. The kit contains Epixa HD (riboflavin 5'-phosphate ophthalmic solution) 0.239% and Epixa (riboflavin 5'-phosphate ophthalmic solution) 0.177%. Label highlights storage instructions and usage notes, including single-dose and topical ophthalmic use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.